RTOG Foundation, Inc.
Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
- Conditions
- Oral ComplicationsHead and Neck Cancer
- Interventions
- Other: Placebo
- First Posted Date
- 2004-09-06
- Last Posted Date
- 2015-11-17
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 249
- Registration Number
- NCT00003139
- Locations
- 🇺🇸
Anne Arundel Oncology Center, Annapolis, Maryland, United States
🇺🇸Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States
🇺🇸Greater Baltimore Medical Center and Cancer Center, Baltimore, Maryland, United States
Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2004-09-03
- Last Posted Date
- 2014-11-21
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 60
- Registration Number
- NCT00002932
- Locations
- 🇺🇸
MBCCOP - LSU Medical Center, New Orleans, Louisiana, United States
🇺🇸CCOP - Baptist Cancer Institute, Memphis, Tennessee, United States
🇺🇸Green Mountain Oncology Group, Rutland, Vermont, United States
Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma
- Conditions
- Sarcoma
- First Posted Date
- 2004-09-02
- Last Posted Date
- 2014-01-24
- Lead Sponsor
- Radiation Therapy Oncology Group
- Registration Number
- NCT00002791
- Locations
- 🇺🇸
Veterans Affairs Medical Center - Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸Veterans Affairs Outpatient Clinic - Martinez, Martinez, California, United States
🇺🇸Harbor Hospital Center, Baltimore, Maryland, United States
Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2004-09-02
- Last Posted Date
- 2013-07-19
- Lead Sponsor
- Radiation Therapy Oncology Group
- Registration Number
- NCT00002873
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸Harbor Hospital Center, Baltimore, Maryland, United States
🇺🇸University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus
- Conditions
- Esophageal Cancer
- First Posted Date
- 2004-08-31
- Last Posted Date
- 2013-11-19
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 298
- Registration Number
- NCT00002631
- Locations
- 🇺🇸
CCOP - Carle Cancer Center, Urbana, Illinois, United States
🇺🇸Siouxland Hematology-Oncology, Sioux City, Iowa, United States
🇺🇸CentraCare Clinic, Saint Cloud, Minnesota, United States
Brachytherapy in Treating Patients With Prostate Cancer
- Conditions
- Prostate Cancer
- First Posted Date
- 2004-08-16
- Last Posted Date
- 2014-01-24
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 95
- Registration Number
- NCT00003312
- Locations
- 🇨🇦
Saint John Regional Hospital, Saint John, New Brunswick, Canada
🇨🇦Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada
🇺🇸CCOP - Columbus, Columbus, Ohio, United States
Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2004-07-19
- Last Posted Date
- 2013-08-13
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 200
- Registration Number
- NCT00002545
- Locations
- 🇺🇸
Lehigh Valley Hospital, Allentown, Pennsylvania, United States
🇺🇸Penn State Geisinger Medical Center, Danville, Pennsylvania, United States
🇺🇸Harbor Hospital Center, Baltimore, Maryland, United States
Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer
- Conditions
- Lung Cancer
- Interventions
- Radiation: stereotactic body radiation therapy
- First Posted Date
- 2004-07-12
- Last Posted Date
- 2019-01-16
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 59
- Registration Number
- NCT00087438
- Locations
- 🇺🇸
M.D. Anderson Cancer Center at University of Texas, Houston, Texas, United States
🇺🇸James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, New York, United States
Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck
- Conditions
- Head and Neck Cancer
- Interventions
- First Posted Date
- 2004-06-11
- Last Posted Date
- 2018-12-12
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 238
- Registration Number
- NCT00084318
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
🇺🇸Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University, Columbus, Ohio, United States
Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery
- Conditions
- Head and Neck Cancer
- Interventions
- Radiation: low-LET cobalt-60 gamma ray therapyDrug: chemotherapyRadiation: low-LET electron therapyRadiation: low-LET photon therapy
- First Posted Date
- 2004-06-10
- Last Posted Date
- 2014-01-24
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 459
- Registration Number
- NCT00002670
- Locations
- 🇺🇸
CCOP - Carle Cancer Center, Urbana, Illinois, United States
🇺🇸CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States
🇺🇸CCOP - Northern New Jersey, Hackensack, New Jersey, United States